Current Mylan CEO Heather Bresch would depart. Mylan President Rajiv Malik, who faces civil suits accusing him of taking part in an alleged price-fixing scheme, would ultimately leave the combined company, one of the people said.(Annett and Griffin, 7/27) Bloomberg: Pfizer's Dealmaker CEO Sharpens Cancer Focus With Mylan Plan Pharmaceutical behemoth Pfizer Inc. has transformed itself under new leadership through a series of spinouts and joint ventures, mitigating risk by placing some units at arm's length while continuing to reap rewards from them. Chief Executive Officer Albert Bourla, 57, who took the helm in January after serving as the drugmaker's operations chief, has rapidly transformed the company through a new deal-making strategy.